Profiel
Kristie Wagner worked as Vice President & Controller at Akebia Therapeutics, Inc. from 2013 to 2021, and then as Vice President & Controller at Entasis Therapeutics Holdings, Inc. in 2021-2022.
She holds a Master's in Business Administration from Suffolk University and an undergraduate degree from Massachusetts College of Liberal Arts.
Eerdere bekende functies van Kristie Wagner
| Bedrijven | Functie | Einde |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-02-2021 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Director of Finance/CFO | - |
Opleiding van Kristie Wagner
| Suffolk University | Masters Business Admin |
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA. | Health Technology |
